Todd D Armstrong

Research Associate

19922017
If you made any changes in Pure these will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 10 Similar Profiles
T-Lymphocytes Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Vaccines Medicine & Life Sciences
Immunotherapy Medicine & Life Sciences
Neoplasm Antigens Medicine & Life Sciences
Cancer Vaccines Medicine & Life Sciences
Immunity Medicine & Life Sciences
Pancreatic Neoplasms Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1992 2017

A STING Agonist Given with OX40 Receptor and PD-L1 Modulators Primes Immunity and Reduces Tumor Growth in Tolerized Mice

Foote, J. B., Kok, M., Leatherman, J. M., Armstrong, T. D., Marcinkowski, B. C., Ojalvo, L. S., Kanne, D. B., Jaffee, E. M., Dubensky, T. W. & Emens, L. A., Jun 1 2017, In : Cancer immunology research. 5, 6, p. 468-479 12 p.

Research output: Contribution to journalArticle

OX40 Receptor
Interferons
Immunity
T-Lymphocytes
Growth

Sorafenib combined with HER-2 targeted vaccination can promote effective T cell immunity in vivo

Sunay, M. M. E., Foote, J. B., Leatherman, J. M., Edwards, J. P., Armstrong, T. D., Nirschl, C. J., Hicks, J. & Emens, L. A., May 1 2017, In : International Immunopharmacology. 46, p. 112-123 12 p.

Research output: Contribution to journalArticle

Immunity
Vaccination
T-Lymphocytes
Neoplasms
Tumor Microenvironment

Vaccines and Their Role in CD8 T Cell-Mediated Antitumor Immunity

Kinkead, H. L., Jaffee, E. M., Lutz, E. R. & Armstrong, T. D., Apr 27 2016, Immunity to Pathogens and Tumors. Elsevier Inc., Vol. 4, p. 534-541 8 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

Tumor Microenvironment
Listeria monocytogenes
Cellular Immunity
Immunotherapy
Cyclophosphamide

Development of thyroglobulin antibodies after GVAX immunotherapy is associated with prolonged survival

De Remigis, A., De Gruijl, T. D., Uram, J. N., Tzou, S. C., Iwama, S., Talor, M. V., Armstrong, T. D., Santegoets, S. J. A. M., Slovin, S. F., Zheng, L., Laheru, D. A., Jaffee, E. M., Gerritsen, W. R., Van Den Eertwegh, A. J. M., Le, D. T. & Caturegli, P., Jan 1 2015, In : International Journal of Cancer. 136, 1, p. 127-137 11 p.

Research output: Contribution to journalArticle

Thyroglobulin
Immunotherapy
Survival
Antibodies
Epitopes

Galectin-3 shapes antitumor immune responses by suppressing CD8 T Cells via LAG-3 and Inhibiting Expansion of Plasmacytoid Dendritic Cells

Kouo, T., Huang, L., Pucsek, A. B., Cao, M., Solt, S., Armstrong, T. & Jaffee, E., Apr 1 2015, In : Cancer immunology research. 3, 4, p. 412-423 12 p.

Research output: Contribution to journalArticle

Galectin 3
Dendritic Cells
T-Lymphocytes
T-Cell Antigen Receptor
Adenocarcinoma